Michael A. Postow

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Natural Language Processing of Radiology Reports to Assess Survival in Patients with Advanced Melanoma

Cancers(2025)10.3390/cancers17091595

Top 100%

0DataRank

Top 100%0 citations

Jordan Eichholz, Varadan Sevilimedu, Natalie Gangai, Danny N. Khalil, Michael A. Postow +2 more

Papers

Driven by 54 papers — median percentile 0. Top paper: “Improved prediction of immune checkpoint blockade efficacy across multiple cancer types”.

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Nature Biotechnology(2021)10.1038/s41587-021-01070-8

N/A

7.3DataRank · unranked

272 citations

Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee +29 more

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Neuro-Oncology(2021)10.1093/neuonc/noab094

N/A

4.0DataRank · unranked

126 citations

Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid +18 more

CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of 89Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262485

N/A

3.7DataRank · unranked

124 citations

Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn +10 more

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Nature Medicine(2024)10.1038/s41591-024-03040-4

N/A

2.1DataRank · unranked

107 citations

Minita Shah, Amanda Frydendahl, Daniel Halmos, Cole C. Khamnei, Nadia Øgaard +56 more

Radiotherapy and Immune Checkpoint Blockade for Melanoma

The Cancer Journal(2017)10.1097/ppo.0000000000000236

N/A

1.9DataRank · unranked

36 citations

Michael A. Postow, Christopher A. Barker, Freddy E. Escorcia

Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS -mutant Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3872

N/A

1.6DataRank · unranked

44 citations

Lisa Zimmer, Kevin B. Kim, Jeffrey A. Sosman, Paolo A. Ascierto, Michael A. Postow +10 more

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-20935-9

N/A

0.920DataRank · unranked

459 citations

Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli +24 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0.910DataRank · unranked

429 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

The association between tumor mutational burden and prognosis is dependent on treatment context

Nature Genetics(2021)10.1038/s41588-020-00752-4

N/A

0.836DataRank · unranked

263 citations

Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel +22 more

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3313

N/A

0.659DataRank · unranked

80 citations

Michael A. Postow, Bartosz Chmielowski, Ryan J. Sullivan, Amita Patnaik, Ezra E.W. Cohen +12 more

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3936

N/A

0.571DataRank · unranked

44 citations

Susan J. Knox, Debra A. Goldman, Yuval Elhanati, Vikram Mavinkurve, Phillip Wong +20 more

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf017

N/A

0.473DataRank · unranked

11 citations

Yonina R. Murciano‐Goroff, Antoine Desîlets, Guilherme Harada, Michael A. Postow, Margaret K. Callahan +9 more

Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment

npj Digital Medicine(2025)10.1038/s41746-024-01387-z

N/A

0.462DataRank · unranked

18 citations

Karolina Bryl, Erin F. Gillespie, Angela Green, Tony Hung, Raymond E. Baser +4 more

Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer

Research Square(2024)10.21203/rs.3.rs-4244833/v1

N/A

0.378DataRank · unranked

7 citations

David A. Knorr, Polina Weitzenfeld, Ning Yao, Maria Baez, M Dilillo +7 more

Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.17.516904

N/A

0.345DataRank · unranked

9 citations

Adam J. Widman, Anushri Arora, Itai Rusinek, William F. Hooper, Rebecca L. Murray +30 more

Scalable topic modelling decodes spatial tissue architecture for large-scale multiplexed imaging analysis

Nature Communications(2025)10.1038/s41467-025-61821-y

N/A

0.257DataRank · unranked

4 citations

James W. Smithy, Mohammad Yosofvand, Caroline E. Kostrzewa, MaryLena Bleile, Fiona Ehrich +6 more

Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2574

N/A

0.241DataRank · unranked

4 citations

Christopher A. Desjardins, Paul A. Giardina, Kankana Bardhan, Swarna Pandian, Keith Halley +14 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9536

N/A

0.115DataRank · unranked

1 citations

Mark Klang, Michael A. Postow, Alexander N. Shoushtari, Ryan J. Sullivan, Jedd D. Wolchok +4 more

Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.24.538095

N/A

0DataRank · unranked

0 citations

Jasme Lee, Matthew Adamow, Colleen Maher, Michael A. Postow, Margaret K. Callahan +3 more

Serum cytokines and autoantibodies to GM-CSF and immune-related colitis in ipilimumab-treated patients with cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12080

N/A

0DataRank · unranked

0 citations

Diane M. Del Valle, Kevin Tuballes, Vanessa Barcessat, Stephanie King, Hsin Huang +11 more

Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis

The Journal of Experimental Medicine(2024)10.1084/jem.20232079

N/A

0DataRank · unranked

12 citations

Diane M. Del Valle, Graham J. Britton, K Mead, Urvija Rajpal, Alice Chen-Liaw +14 more

Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients

European Journal of Cancer(2024)10.1016/j.ejca.2024.115119

N/A

0DataRank · unranked

14 citations

G.V. Long, John O. Larkin, Jedd D. Wolchok, J.C. Hassel, D. Schadendorf +16 more

Fertility outcomes post immune checkpoint inhibitor exposure

Cancer Cell(2024)10.1016/j.ccell.2024.10.005

N/A

0DataRank · unranked

7 citations

Martinique Ogle, Erin O’Brien, Callahan M. Wilde, Jenna Sinopoli, Jill Weiss +6 more

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

Frontiers in Immunology(2024)10.3389/fimmu.2024.1340979

N/A

0DataRank · unranked

4 citations

Eleonora Pagan, Laura Pala, Chiara Oriecuia, Marco Musca, Claudia Specchia +8 more

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

Cancer Cell(2025)10.1016/j.ccell.2025.07.013

N/A

0DataRank · unranked

30 citations

David A. Knorr, Polina Weitzenfeld, Lucas Blanchard, Ning Yao, Maria Baez +10 more

Top advances of the year: Neoadjuvant immunotherapy in melanoma

Cancer(2025)10.1002/cncr.35877

N/A

0DataRank · unranked

2 citations

Michael A. Postow, Monica F. Chen

Pretreatment naive T cells are associated with severe irAE following PD-1/CTLA-4 checkpoint blockade for melanoma

JCI Insight(2025)10.1172/jci.insight.198203

N/A

0DataRank · unranked

2 citations

Alice Horisberger, Mehreen Elahee, I. Adejoorin, Nilasha Ghosh, Michael A. Postow +4 more

Natural Language Processing of Radiology Reports to Assess Survival in Patients with Advanced Melanoma

Cancers(2025)10.3390/cancers17091595

Top 100%

0DataRank

Top 100%0 citations

Jordan Eichholz, Varadan Sevilimedu, Natalie Gangai, Danny N. Khalil, Michael A. Postow +2 more

International real-world study of combination immunotherapy sequences in metastatic melanoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012225

N/A

0DataRank · unranked

0 citations

Sarah E. Lochrin, James W. Smithy, Michael A. Postow, Caroline Gaudy‐Marqueste, Nausicaa Malissen +28 more

Immune checkpoint inhibitors to treat cutaneous malignancies

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.03.131

N/A

0DataRank · unranked

92 citations

H. Mytrang, Gregory S. Phillips, Michael A. Postow, Tomoko Akaike, Paul Nghiem +2 more

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4189

N/A

0DataRank · unranked

54 citations

Walid K. Chatila, Arshi Arora, Francisco Sánchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa +18 more

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1898105

N/A

0DataRank · unranked

25 citations

Hassane M. Zarour, Hussein A. Tawbi, John M. Kirkwood, Michael A. Postow, Philip Friedlander +11 more

Dermatologic infections in cancer patients treated with checkpoint inhibitors

Journal of the American Academy of Dermatology(2021)10.1016/j.jaad.2021.03.039

N/A

0DataRank · unranked

8 citations

Dulce M. Barrios, Gregory S. Phillips, Michael A. Postow, Allison Betof Warner, Jonathan E. Rosenberg +4 more

Deciphering radiological stable disease to immune checkpoint inhibitors

Annals of Oncology(2022)10.1016/j.annonc.2022.04.450

N/A

0DataRank · unranked

50 citations

Song Wu, Hira Rizvi, Q. Zhang, Jacklynn V. Egger, Juan C. Osorio +14 more

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma

Frontiers in Immunology(2022)10.3389/fimmu.2021.810388

N/A

0DataRank · unranked

21 citations

James W. Smithy, Michael A. Postow, Allison Betof Warner, Kimberly Loo

Ensuring equity in the era of HLA-restricted cancer therapeutics

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005600

N/A

0DataRank · unranked

15 citations

Amanda G. Blouin, Lisa C. Diamond, Michael A. Postow, James W. Smithy

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series

The Oncologist(2022)10.1093/oncolo/oyac019

N/A

0DataRank · unranked

10 citations

Michael A. Postow, David M. Faleck, Jessica Harris

Adjuvant checkpoint blockade following complete local therapy for melanoma metastases

The Lancet(2022)10.1016/s0140-6736(22)01748-2

N/A

0DataRank · unranked

5 citations

Michael A. Postow, James W. Smithy

Standardized guidelines for acral and nail unit melanoma treatment are lacking

Journal of the American Academy of Dermatology(2022)10.1016/j.jaad.2022.08.024

N/A

0DataRank · unranked

2 citations

Michael A. Postow, Shari R. Lipner, Julianne M. Falotico

375: CONCURRENT IMMUNE CHECKPOINT INHIBITION AND SELECTIVE IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH IMMUNE-RELATED ENTEROCOLITIS

Gastroenterology(2022)10.1016/s0016-5085(22)60201-4

N/A

0DataRank · unranked

1 citations

Fangwen Zou, Sienna Durbin, Barbara E. Dutra, Donna Leet, Hamzah Abu‐Sbeih +8 more

Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.17.476508

N/A

0DataRank · unranked

17 citations

Minita Shah, Nadia Øgaard, Cole C. Khamnei, Amanda Frydendahl, Aditya Deshpande +37 more

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007195

N/A

0DataRank · unranked

28 citations

Fangwen Zou, Sienna Durbin, Barbara E. Dutra, Hamzah Abu‐Sbeih, Anusha Shirwaikar Thomas +11 more

Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad150

N/A

0DataRank · unranked

21 citations

I‐Hsin Lin, James Flory, Hans Gerdes, Michael A. Postow, David M. Faleck +1 more

Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure

CNS Oncology(2023)10.2217/cns-2022-0014

N/A

0DataRank · unranked

12 citations

Anne S. Reiner, Ryka R Sehgal, Katherine S. Panageas, Allison Betof Warner, Michael A. Postow +2 more

Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes

The Oncologist(2023)10.1093/oncolo/oyad226

N/A

0DataRank · unranked

7 citations

Deepika Satish, Ngolela Esther Babady, Mini Kamboj, Michael A. Postow, Monika Laszkowska +2 more

A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100546

N/A

0DataRank · unranked

6 citations

Jasme Lee, Matthew Adamow, Colleen Maher, Michael A. Postow, Margaret K. Callahan +3 more

Accelerating the Evolution of Immune-Related Enterocolitis Management

Journal of Clinical Oncology(2023)10.1200/jco.22.02914

N/A

0DataRank · unranked

11 citations

Michael Dougan, Monique Tello, Joseph E. Grossman, Alan C. Moss, Michael A. Postow +1 more

Data from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma

(2023)10.1158/1078-0432.c.6532311

N/A

0DataRank · unranked

0 citations

Lisa Zimmer, Kevin B. Kim, Jeffrey A. Sosman, Paolo A. Ascierto, Michael A. Postow +10 more

Data from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

(2023)10.1158/1078-0432.c.6530294

Top 100%

0DataRank

Top 100%0 citations

Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski +17 more

Michael A. Postow

Indexed papers

Top data-sharing exemplar

Papers